Clinical Trial Update: Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens [NA]

View source ↗

Summary

A clinical trial evaluating the performance of the enVista Aspire intraocular lens for cataract treatment has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• enVista Aspire intraocular lens (intraocular lens)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Cataract | NA | Status: TERMINATED